Scientific deep-dive

Feeling Cold and Night Sweats on a GLP-1: What the Labels and Studies Show

No GLP-1 label lists feeling cold, chills or night sweats, and no study has measured body temperature on Ozempic or Mounjaro. What weight loss does to temperature, why sweating can mean low blood sugar, and when the thyroid is the cause.

By Ruth Calder · Enforcement Editor
Editorially reviewed (not clinically reviewed). Not medical advice · How we verify contentLast reviewed
11 min read·28 citations

Part of Safety and side effects, separated from the headlines

No trial has measured body temperature in people taking Ozempic, Wegovy, Mounjaro or Zepbound, and none of their labels lists chills, feeling cold, excess sweating or night sweats as a side effect.[1][3] People report all four anyway. The best-supported explanation for feeling cold is the weight loss and the smaller meals, not a direct drug effect: in a diet trial, core temperature fell as people lost about 10% of their weight.[8] Sweating is different. Every label lists it as a sign of low blood sugar, and that risk sits mostly with people whose regimen already includes insulin or a sulfonylurea.[1] Thyroid problems, menopause and other medicines explain many of the rest.

About this article. Side-effect information comes from the current FDA labels on DailyMed. Study results come from the published papers, and the text says plainly when a study was done in rats or mice rather than people. FDA adverse event report counts were pulled from the agency’s public database; they count reports, not proven side effects. This is not medical advice, and nothing here is a reason to change a dose. Calories burned and metabolic rate are covered separately in does Ozempic slow your metabolism.

What the labels say: nothing about feeling cold

We searched the full current label of each major GLP-1 drug for chills, cold, hyperhidrosis (the medical term for excess sweating), night sweats, temperature and fever. The result was the same across all six. None lists feeling cold or chills as an adverse reaction. The word “cold” appears only in the pen storage instructions. Sweating appears once in each, inside the patient guide’s list of low-blood-sugar symptoms.[1][2]

Where cold, chills, sweating and fever appear in each current GLP-1 label (DailyMed, October 2026).
LabelChills or feeling coldExcess sweating or night sweatsWhere sweating or fever does appear
Ozempic injection[1]Not listedNot listedSweating as a low blood sugar sign; fever as a gallbladder sign
Wegovy injection and tablet[2]Not listedNot listedSame two places
Mounjaro[3]Not listedNot listedSame two places
Zepbound[4]Not listedNot listedSame two places
Rybelsus and Ozempic tablets[5]Not listedNot listedSame, plus fever as a reason a diabetes dose may need changing
Saxenda[6]Not listedNot listedFever in 8% of treated children vs 7.1% on placebo

Absence from a label does not prove a drug never does something. Adverse reaction tables list events that happened more often on the drug than on placebo in trials, usually at a frequency cutoff, so a mild, subjective feeling of being cold could go uncounted. It does mean that in trials of tens of thousands of people, nothing about temperature stood out enough to make the list.

What people report to FDA

FDA’s adverse event reporting system collects reports from patients, doctors and manufacturers. Anyone can file one, nobody checks whether the drug caused the problem, and popular drugs collect more reports simply because more people take them. The counts below are reports that list each drug and each symptom, through June 2026.[7]

FDA adverse event reports (FAERS) naming each drug and each symptom, queried October 17, 2026. These are reports, not confirmed side effects or rates.
Reported termSemaglutide reportsTirzepatide reports
All reports for the drug73,001160,663
Chills379530
Feeling cold117263
Excess sweating (hyperhidrosis)497426
Cold sweat105132
Night sweats7398
Body temperature decreased2016
Hypothermia2117
Low blood sugar (hypoglycemia), for comparison412747

Each temperature term turns up in well under 1% of the reports for either drug. That is a signal that people notice these symptoms and connect them to the drug. It is not evidence of how often the drug causes them, or whether it does at all. A study of nearly 60,000 Facebook posts about GLP-1 drugs found sweating mentioned in the same cluster as hypoglycemia, dizziness and dehydration,[28] which fits the label’s own link between sweating and low blood sugar.

Why losing weight can make you feel colder

Feeling cold after major weight loss is not unique to these drugs. The human evidence comes from diet studies, and it points to three mechanisms. None has been tested directly in people on a GLP-1, so treat their application to Ozempic or Mounjaro as inference.

The body runs slightly cooler on fewer calories. In a six-month randomized trial at Pennington Biomedical, 48 overweight adults were assigned to a maintenance diet, a 25% calorie cut, a smaller cut plus exercise, or a very low-calorie diet. Those cutting calories lost about 10% of their weight, and core body temperature fell in both calorie-restriction groups.[8] The larger two-year CALERIE 2 trial, in 218 people, found little difference in core temperature between groups, but blood levels of T3, the active thyroid hormone that sets the pace of heat production, fell more in the restricted group at one and two years.[9] A small study at Columbia found that holding weight 10% below its usual level lowered T3, T4 and leptin.[10] Lower thyroid hormone at a lower weight is an adaptation, not thyroid disease.

Smaller meals make less heat. Digesting food produces heat, a small effect called diet-induced thermogenesis. In a 2000 crossover study of 20 healthy young men, an infusion of GLP-1 cut the heat produced after a fixed breakfast by 47% compared with saline, which the authors attributed to slower absorption of the meal.[11] Someone eating far less on a GLP-1 also generates less of that heat across the day. Whether either effect is large enough to feel has not been studied.

Fat insulates, a little. In an NIH study that cooled men in a calorimetry room, men with obesity had more insulation from fat but did not tolerate cold any better: both groups reached their coldest bearable temperature at similar skin temperatures.[12] In 110 young adults, women with more body fat and lean mass took longer to start shivering when cooled; men showed no such link.[13] Losing a lot of fat could plausibly make some people, women especially, feel the cold sooner. No study has tested that after GLP-1 weight loss.

Metabolic rate itself is a separate question with better data. The studies that measured it on semaglutide and tirzepatide found the drop roughly matched the weight lost; the details are in our metabolism review.

Does the drug itself change body temperature?

In people, nobody knows, because nobody has measured it. The direct evidence on GLP-1 drugs and temperature is almost entirely from rodents, and it does not point one way.

Studies of GLP-1 drugs and body temperature. Only the last three involved people, and none measured core temperature.
StudySpeciesWhat it found
de Sousa 2025[14]RatsLiraglutide injection lowered body temperature in normal and feverish rats
Byun 2025[15]RatsSemaglutide prevented the drop in temperature seen in rats fed the same reduced amount without the drug
McLear 2026[16]MiceLiraglutide stopped food-restricted mice from entering torpor, a cold, energy-saving state
Rinaman 2000[17]RatsBlocking brain GLP-1 receptors made fevers higher; the blocker alone did not change temperature
Janssen 2020[18]24 men without diabetes12 weeks of exenatide raised brown fat activity on PET scans 28% without changing resting calorie burn
van Eyk 2020[19]50 adults with type 2 diabetesLiraglutide lowered resting calorie burn early and did not change brown fat on MRI
Harrison 2025[20]One woman on semaglutideWidespread brown fat activity on a PET scan was mistaken for spreading cancer

The rat studies conflict. One found liraglutide cooled rats; another found semaglutide kept dieting rats warmer than diet alone. Brown fat, the tissue that burns energy to make heat, lit up more on scans after exenatide in one small human study but not after liraglutide in another. A brown fat scan reading is not body temperature, and rodents rely on brown fat for warmth far more than adults do. None of this shows that a GLP-1 drug makes a person colder or warmer.

Night sweats: check blood sugar first

The one place sweating appears on these labels is the list of low-blood-sugar warning signs. The labels tie the risk to other diabetes medicines:

Your risk for getting low blood sugar may be higher if you use OZEMPIC with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin.
— Ozempic Medication Guide, DailyMed

Mounjaro and Zepbound carry the same warning, naming the same two drug types.[3][4] The sweating, shakiness, hunger and fast heartbeat that come with a low can happen at any hour. Waking up drenched, with a headache or a racing heart, is worth checking with a glucose meter if you take insulin or a sulfonylurea such as glipizide or glimepiride. That is an inference from the label’s symptom list; no GLP-1 label uses the words “night sweats.” Who is actually at risk is covered in GLP-1 low blood sugar risk.

Counterfeit pens are the exception for people without diabetes. Dutch doctors reported two people with neither diabetes nor obesity who injected semaglutide bought without a prescription and arrived in a coma with severe low blood sugar, low potassium and a low body temperature. The product contained insulin. The authors note that semaglutide alone does not cause meaningful hypoglycemia in healthy people.[21] Sudden sweating, shaking or confusion after a dose from an unofficial source is an emergency.

Most night sweats have nothing to do with any of this. In a survey of 2,267 adults in US primary care, 41% said they had had night sweats in the past month, most never mentioned them to a doctor, and they were linked to hot flashes, panic attacks, sleep problems, antidepressants including SSRIs, higher weight and, in men, alcohol.[22] A systematic review concluded that night sweats are a nonspecific symptom, linked to menopause, cancers, autoimmune disease and infections, but usually found in people with none of them.[23] Many people starting a GLP-1 are women in their 40s and 50s, the ages when menopausal hot flashes and night sweats peak, so timing alone can mislead.

When the thyroid is the real cause

Feeling cold is one of the classic symptoms of an underactive thyroid, alongside tiredness, lethargy, weight gain, constipation and dry skin.[24] Those symptoms overlap with what people blame on a GLP-1, and a Danish study of 140 newly diagnosed patients found no single symptom reliable enough to rule the condition in or out. Its authors’ advice: even minor suspicion should lead to a blood test.[25]

A 2026 case report shows how the two can tangle. A 54-year-old woman developed fatigue and new cold intolerance after losing 22 kg in four months on semaglutide. Her T3 was low with a normal TSH, a pattern called euthyroid sick syndrome that reflects the body’s response to rapid weight loss rather than thyroid disease. Her symptoms resolved as her weight stabilized and her eating improved, without thyroid medicine.[26] One case proves nothing about frequency. It does show why a thyroid panel, read by someone who knows the patient is losing weight fast, is a reasonable step.

The opposite problem produces sweating. If you take levothyroxine and lose a lot of weight, your old dose can become too high. The Synthroid label lists heat intolerance, fever and excessive sweating among the effects of too much thyroid hormone.[27] A study of Medicare patients found that thyroid testing did not increase after people started a GLP-1, as described in the thyroid test nobody reordered. How the dose interacts with these drugs is set out in levothyroxine and a GLP-1.

Cold all over versus cold hands and feet

Feeling chilled through is not the same as hands and feet that are cold, tingling or burning. The Wegovy label does list a group of altered skin sensations, called dysesthesia, that includes tingling, burning and sensitive skin, and it becomes more common at higher doses: 22% on the 7.2 mg injection against 6% on 2.4 mg and 0.3% on placebo.[2] Those are nerve sensations, not body temperature. They are covered in Ozempic and your hands and feet. A racing heart with sweating has its own guide in GLP-1 heart rate and palpitations.

When feeling cold or sweaty needs a doctor

  • Sweating with shakiness, confusion, hunger or a racing heart, especially when insulin or a sulfonylurea is part of your treatment. Check your glucose and treat a low as your diabetes plan says.[1]
  • Any of those symptoms after a dose bought outside a pharmacy. Counterfeit semaglutide containing insulin has put people in a coma.[21]
  • Fever with pain in the upper right abdomen, yellow skin or eyes, or pale stools. The labels list these together as gallbladder warning signs.[1][3]
  • Drenching night sweats with fever, or weight loss beyond what your dose explains. Night sweats are linked to infections and cancers as well as harmless causes.[23] On a GLP-1, weight loss is expected, which makes it easy to miss when it is not the drug. Tell your prescriber how fast you are losing and whether that changed.
  • Cold intolerance with worsening fatigue, constipation, dry skin or hair loss, or sweating and heat intolerance if you take levothyroxine. Ask for a thyroid test.[25][27]
  • Shivering, drowsiness or confusion with a low measured temperature. That is not ordinary chilliness and needs urgent care.

If none of those apply and you simply feel colder than you used to, the evidence suggests that is the cost of eating less and weighing less. Regular meals with enough protein, layers and staying active are the practical answers, and the feeling is worth mentioning at your next appointment rather than ignoring. Tiredness that comes with it is covered in what causes fatigue on a GLP-1.

Frequently Asked Questions

Feeling cold is not listed as a side effect on the Ozempic, Wegovy, Mounjaro or Zepbound labels, and no study has measured body temperature in people taking them. People do report it. The best-supported explanation is the weight loss and smaller meals: in a diet trial, core body temperature fell as people lost about 10% of their weight, and thyroid hormone levels drop at a lower weight.
The Mounjaro and Zepbound labels do not list chills or feeling cold. FDA has received 263 reports of feeling cold and 530 of chills naming tirzepatide out of more than 160,000 reports, but reports do not show that the drug caused the symptom. The same weight-loss explanations apply to tirzepatide as to semaglutide.
Sweating is listed on every GLP-1 label as a sign of low blood sugar, and the people most exposed are those whose treatment includes insulin or a sulfonylurea. If that is you, check your glucose. Otherwise, night sweats are very common in adults and are often linked to menopause, antidepressants, alcohol, anxiety or sleep problems. Fever or unexplained weight loss alongside them needs a doctor.
It can be. Cold intolerance is a classic symptom of an underactive thyroid, and no single symptom reliably rules it in or out, so a blood test is reasonable if you are also tired, constipated or have dry skin. Rapid weight loss can also lower T3 without thyroid disease, which usually settles once weight stabilizes.
Chills are not on either label. Chills with a fever can signal an infection or, with upper abdominal pain or yellowing skin, a gallbladder problem, which the labels do list. Chills with sweating and shakiness can be low blood sugar. Chills alone, without any of those, have no established link to the drugs.

References

  1. 1.Novo Nordisk OZEMPIC (semaglutide) injection: Prescribing Information and Medication Guide DailyMed, National Library of Medicine. 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79
  2. 2.Novo Nordisk WEGOVY (semaglutide) injection and tablet: Prescribing Information and Medication Guide DailyMed, National Library of Medicine. 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
  3. 3.Eli Lilly and Company MOUNJARO (tirzepatide) injection: Prescribing Information and Medication Guide DailyMed, National Library of Medicine. 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0
  4. 4.Eli Lilly and Company ZEPBOUND (tirzepatide) injection: Prescribing Information and Medication Guide DailyMed, National Library of Medicine. 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
  5. 5.Novo Nordisk RYBELSUS and OZEMPIC (semaglutide) tablets: Prescribing Information and Medication Guide DailyMed, National Library of Medicine. 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=27f15fac-7d98-4114-a2ec-92494a91da98
  6. 6.Novo Nordisk SAXENDA (liraglutide) injection: Prescribing Information DailyMed, National Library of Medicine. 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143
  7. 7.U.S. Food and Drug Administration FDA Adverse Event Reporting System (FAERS), openFDA drug adverse event endpoint, queried October 17, 2026 openFDA. 2026. https://open.fda.gov/data/faers/
  8. 8.Heilbronn LK, de Jonge L, Frisard MI, et al. Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals: a randomized controlled trial JAMA. 2006. PMID: 16595757.
  9. 9.Ravussin E, Redman LM, Rochon J, et al. A 2-Year Randomized Controlled Trial of Human Caloric Restriction: Feasibility and Effects on Predictors of Health Span and Longevity J Gerontol A Biol Sci Med Sci. 2015. PMID: 26187233.
  10. 10.Rosenbaum M, Murphy EM, Heymsfield SB, et al. Low dose leptin administration reverses effects of sustained weight-reduction on energy expenditure and circulating concentrations of thyroid hormones J Clin Endocrinol Metab. 2002. PMID: 11994393.
  11. 11.Flint A, Raben A, Rehfeld JF, et al. The effect of glucagon-like peptide-1 on energy expenditure and substrate metabolism in humans Int J Obes Relat Metab Disord. 2000. PMID: 10757621.
  12. 12.Brychta RJ, Huang S, Wang J, et al. Quantification of the Capacity for Cold-Induced Thermogenesis in Young Men With and Without Obesity J Clin Endocrinol Metab. 2019. PMID: 31150063.
  13. 13.Sardjoe Mishre ASD, Martinez-Tellez B, Acosta FM, et al. Association of shivering threshold time with body composition and brown adipose tissue in young adults J Therm Biol. 2022. PMID: 36031206.
  14. 14.de Sousa GLS, da Cruz EKM, de Aguiar SCR, et al. The GLP-1 Analog Liraglutide Reduces Fever Through Sex-Dependent Neuroinflammatory Modulation Pharmaceuticals (Basel). 2025. PMID: 41304982.
  15. 15.Byun S, Sotzen MR, Knappenberger MA, et al. Advantage of Semaglutide: Comprehensive Analysis of Metabolic Impact of Semaglutide-Treated and Pair-Fed Rats Compr Physiol. 2025. PMID: 41405347.
  16. 16.McLear GM, Kakarla AR, Taylor CE, Swoap SJ Inhibition of daily torpor in mice requires calories, not just feeding: a potential role for GLP-1 J Comp Physiol B. 2026. PMID: 41806000.
  17. 17.Rinaman L, Comer J Antagonism of central glucagon-like peptide-1 receptors enhances lipopolysaccharide-induced fever Auton Neurosci. 2000. PMID: 11189034.
  18. 18.Janssen LGM, Nahon KJ, Bracké KFM, et al. Twelve weeks of exenatide treatment increases [18F]fluorodeoxyglucose uptake by brown adipose tissue without affecting oxidative resting energy expenditure in nondiabetic males Metabolism. 2020. PMID: 31982480.
  19. 19.van Eyk HJ, Paiman EHM, Bizino MB, et al. Liraglutide decreases energy expenditure and does not affect the fat fraction of supraclavicular brown adipose tissue in patients with type 2 diabetes Nutr Metab Cardiovasc Dis. 2020. PMID: 32127340.
  20. 20.Harrison DB, Phillips AL, Tansey JB, et al. Brown Adipose Tissue Mimicking Head and Neck Cancer on PET Scan in a Patient on GLP-1 Drug Laryngoscope. 2025. PMID: 39370986.
  21. 21.Stammers J, Hofste Op Bruinink D, Karel PGA, et al. Insulin intoxications caused by falsified semaglutide (article in Dutch) Ned Tijdschr Geneeskd. 2026. PMID: 42390457.
  22. 22.Mold JW, Mathew MK, Belgore S, DeHaven M Prevalence of night sweats in primary care patients: an OKPRN and TAFP-Net collaborative study J Fam Pract. 2002. PMID: 12019054.
  23. 23.Mold JW, Holtzclaw BJ, McCarthy L Night sweats: a systematic review of the literature J Am Board Fam Med. 2012. PMID: 23136329.
  24. 24.Taylor PN, Medici MM, Hubalewska-Dydejczyk A, et al. Hypothyroidism Lancet. 2024. PMID: 39368843.
  25. 25.Carlé A, Pedersen IB, Knudsen N, et al. Hypothyroid symptoms and the likelihood of overt thyroid failure: a population-based case-control study Eur J Endocrinol. 2014. PMID: 25305308.
  26. 26.Elmezayen ZW, Qrareya F, Abdallah A, et al. Euthyroid Sick Syndrome Precipitated By Rapid Weight Loss Following Semaglutide Initiation: A Case Report Clin Med Insights Endocrinol Diabetes. 2026. PMID: 42052217.
  27. 27.AbbVie SYNTHROID (levothyroxine sodium) tablets: Prescribing Information DailyMed, National Library of Medicine. 2024. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1e11ad30-1041-4520-10b0-8f9d30d30fcc
  28. 28.Alibilli AS, Jain V, Mane H, et al. Harnessing Facebook to Investigate Real-World Mentions of Adverse Events of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Medications: Observational Study of Facebook Posts From 2022 to 2024 JMIR Infodemiol. 2025. PMID: 40706081.

Ozempic Dreams and Nightmares: What the Evidence Shows

No study has measured dreams on Ozempic, Wegovy, Mounjaro or Zepbound, and none of the labels lists abnormal dreams or nightmares. What FDA reports, signal studies and sleep research do show, and when night-time low blood sugar is the real cause.

9 min read

Intermittent Fasting on a GLP-1: What Has Been Tested and What Has Not

No trial has added intermittent fasting or a 16:8 eating window to semaglutide or tirzepatide. What the fasting trials show on their own, and the risks that matter on a GLP-1: protein, low blood sugar, fluids, the oral tablet's morning rule and gallstones.

10 min read

Levothyroxine and a GLP-1: Why Your Thyroid Dose May Need to Come Down

Levothyroxine and a GLP-1 can be taken together. Semaglutide tablets raised thyroxine exposure 33% in a dedicated study, and weight loss lowers the dose most people need. On an unchanged dose both push TSH down, not up.

11 min read

GLP-1s and Autoimmune Thyroiditis: An Association, and the Reason to Doubt It

A 290,770-pair cohort found autoimmune thyroiditis diagnosed 30% more often on a GLP‑1 than on a DPP-4 inhibitor. Everyone on a GLP‑1 gets a boxed thyroid warning and the comparison group does not, and this disease is found by testing.

6 min read

Antidepressants and a GLP-1: Ozempic, Wellbutrin, Lexapro and What the Labels Say

No GLP-1 label names an antidepressant as an interaction, and people on antidepressants lost as much weight on semaglutide as everyone else. The real overlaps: stacked nausea, slowed absorption of tablets, and two bupropion rules.

11 min read

Can Ozempic or Mounjaro Cause Liver Damage? Liver Enzymes Evidence Review

Liver injury on semaglutide or tirzepatide is rare. Trial ALT levels fall on average, no label carries a liver warning, and about 31 suspected cases have been published. Gallstones are the likelier cause of a raised liver test, and jaundice or dark urine needs same-day care.

11 min read

Where to get tirzepatide (Mounjaro / Zepbound) online, safely: sellers our editors have checked

These are telehealth sellers our editors have checked. For each one we hold a price, the form the drug comes in, and the states it reaches.

No insurance needed · vetted by our editors

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

7.4

Wellorithm

Compounded semaglutide at a flat $247 every 28 days, any dose

7.3

Willow

Seeing what it charges before you answer any medical questions

7.1

MyDrHank

An oral route if you will not self-inject